Today: 18 May 2026
Browse Category

NASDAQ:NBIX 7 April 2026

Soleno Therapeutics Pulls Europe Drug Filing After $2.9 Billion Neurocrine Deal

Soleno Therapeutics Pulls Europe Drug Filing After $2.9 Billion Neurocrine Deal

Soleno Therapeutics withdrew its European filing for VIOKAT on Tuesday, halting a regulatory review that was expected to conclude in 2026. The move came one day after Neurocrine Biosciences agreed to acquire Soleno for $2.9 billion in cash, or $53 a share. Vykat XR, Soleno’s only marketed product, generated $190.4 million in 2025 U.S. sales. Neurocrine said it has no immediate plans for a European launch.
7 April 2026
···
Soleno Therapeutics Stock Jumps After Neurocrine’s $2.9 Billion Bet on Vykat XR

Soleno Therapeutics Stock Jumps After Neurocrine’s $2.9 Billion Bet on Vykat XR

Neurocrine Biosciences will acquire Soleno Therapeutics for $53 a share in cash, valuing Soleno at $2.9 billion. The deal gives Neurocrine Vykat XR, the only FDA-approved treatment for hyperphagia in Prader-Willi syndrome. Soleno shares last traded at $52.25. The transaction is expected to close within 90 days, pending regulatory and shareholder approval.
7 April 2026
···

Stock Market Today

  • AIAI Holdings Joins NASDAQ Composite, Implications for Future Dividends
    May 18, 2026, 2:00 AM EDT. AIAI Holdings completed a direct listing on the NASDAQ Global Market and joined the NASDAQ Composite Index, enhancing its access to U.S. equity markets and index-linked capital. The move positions AIAI alongside major technology stocks and may influence liquidity and investor mix due to index fund activity. Despite the listing, AIAI has under US$1 million in revenue and negative shareholders' equity, limiting current dividend prospects. The company's focus remains on acquisitions and AI-driven growth. For income investors, the potential for dividends hinges on future revenue stability, equity improvement, and free cash flow generation. The NASDAQ listing boosts capital raising options, which could shape dividend strategies over time.

Latest articles

Rigetti Stock Struggles, Demand for Answers Grows

Rigetti Stock Struggles, Demand for Answers Grows

18 May 2026
Rigetti shares fell 7.37% Friday to $17.85, down about 5.8% for the week, amid heavy trading after earnings. The company reported Q1 revenue of $4.4 million and an operating loss of $26 million. Nasdaq Composite lost 1.5% Friday, while other quantum stocks also declined. CEO Subodh Kulkarni is set to speak at a virtual symposium May 21.
Super Micro Shares Slip, Eyes on Monday for SMCI

Super Micro Shares Slip, Eyes on Monday for SMCI

18 May 2026
Super Micro Computer shares closed at $31.04 Friday, down 6% on the day and 12.2% since May 8, as the Nasdaq fell 1.54%. The company reports $10.24 billion in March-quarter sales, missing analyst estimates and down from $12.7 billion the prior quarter, with a 9.9% gross margin and $6.6 billion in operating cash outflow. Management will address investors Monday at a J.P. Morgan conference.
Exxon to Be Watched Monday After Oil Rally and Court Ruling

Exxon to Be Watched Monday After Oil Rally and Court Ruling

18 May 2026
Exxon Mobil closed Friday at $157.92, up 3.4%, after a surge in crude prices lifted energy stocks. Brent crude settled at $109.26 a barrel and WTI at $105.42, both jumping on concerns over shipping near the Strait of Hormuz. A Texas jury found Exxon not liable in a long-running investor lawsuit. Trading resumes Monday; U.S. markets are closed for the weekend.
Go toTop